Serum Amino Acid Profiling in Citrin-Deficient Children Exhibiting Normal Liver Function During the Apparently Healthy Period.
Age-matched control study
Amino acids
Energy metabolism
Gluconeogenesis
Mitochondria transporter
Urea cycle
Journal
JIMD reports
ISSN: 2192-8304
Titre abrégé: JIMD Rep
Pays: United States
ID NLM: 101568557
Informations de publication
Date de publication:
2019
2019
Historique:
received:
09
08
2017
accepted:
27
02
2018
revised:
23
02
2018
pubmed:
15
4
2018
medline:
15
4
2018
entrez:
15
4
2018
Statut:
ppublish
Résumé
Citrin (mitochondrial aspartate-glutamate transporter) deficiency causes the failures in both carbohydrate-energy metabolism and the urea cycle, and the alterations in the serum levels of several amino acids in the stages of newborn (NICCD) and adult (CTLN2). However, the clinical manifestations are resolved between the NICCD and CTLN2, but the reasons are still unclear. This study evaluated the serum amino acid profile in citrin-deficient children during the healthy stage. Using HPLC-MS/MS analysis, serum amino acids were evaluated among 20 citrin-deficient children aged 5-13 years exhibiting normal liver function and 35 age-matched healthy controls. The alterations in serum amino acids characterized in the NICCD and CTLN2 stages were not observed in the citrin-deficient children. Amino acids involved in the urea cycle, including arginine, ornithine, citrulline, and aspartate, were comparable in the citrin-deficient children to the respective control levels, but serum urea was twofold higher, suggestive of a functional urea cycle. The blood sugar level was normal, but glucogenic amino acids and glutamine were significantly decreased in the citrin-deficient children compared to those in the controls. In addition, significant increases of ketogenic amino acids, branched-chain amino acids (BCAAs), a valine intermediate 3-hydroxyisobutyrate, and β-alanine were also found in the citrin-deficient children. The profile of serum amino acids in the citrin-deficient children during the healthy stage showed different characteristics from the NICCD and CTLN2 stages, suggesting that the failures in both urea cycle function and energy metabolism might be compensated by amino acid metabolism. In the citrin-deficient children during the healthy stage, the characteristics of serum amino acids, including decrease of glucogenic amino acids, and increase of ketogenic amino acids, BCAAs, valine intermediate, and β-alanine, were found by comparison to the age-matched healthy control children, and it suggested that the characteristic alteration of serum amino acids may be resulted from compensation for energy metabolism and ammonia detoxification.
Sections du résumé
BACKGROUND
BACKGROUND
Citrin (mitochondrial aspartate-glutamate transporter) deficiency causes the failures in both carbohydrate-energy metabolism and the urea cycle, and the alterations in the serum levels of several amino acids in the stages of newborn (NICCD) and adult (CTLN2). However, the clinical manifestations are resolved between the NICCD and CTLN2, but the reasons are still unclear. This study evaluated the serum amino acid profile in citrin-deficient children during the healthy stage.
METHODS
METHODS
Using HPLC-MS/MS analysis, serum amino acids were evaluated among 20 citrin-deficient children aged 5-13 years exhibiting normal liver function and 35 age-matched healthy controls.
RESULTS
RESULTS
The alterations in serum amino acids characterized in the NICCD and CTLN2 stages were not observed in the citrin-deficient children. Amino acids involved in the urea cycle, including arginine, ornithine, citrulline, and aspartate, were comparable in the citrin-deficient children to the respective control levels, but serum urea was twofold higher, suggestive of a functional urea cycle. The blood sugar level was normal, but glucogenic amino acids and glutamine were significantly decreased in the citrin-deficient children compared to those in the controls. In addition, significant increases of ketogenic amino acids, branched-chain amino acids (BCAAs), a valine intermediate 3-hydroxyisobutyrate, and β-alanine were also found in the citrin-deficient children.
CONCLUSION
CONCLUSIONS
The profile of serum amino acids in the citrin-deficient children during the healthy stage showed different characteristics from the NICCD and CTLN2 stages, suggesting that the failures in both urea cycle function and energy metabolism might be compensated by amino acid metabolism.
SYNOPSIS
CONCLUSIONS
In the citrin-deficient children during the healthy stage, the characteristics of serum amino acids, including decrease of glucogenic amino acids, and increase of ketogenic amino acids, BCAAs, valine intermediate, and β-alanine, were found by comparison to the age-matched healthy control children, and it suggested that the characteristic alteration of serum amino acids may be resulted from compensation for energy metabolism and ammonia detoxification.
Identifiants
pubmed: 29654547
doi: 10.1007/8904_2018_99
pmc: PMC6323014
doi:
Types de publication
Journal Article
Langues
eng
Pagination
53-61Références
Nat Genet. 1999 Jun;22(2):159-63
pubmed: 10369257
Hum Genet. 2000 Dec;107(6):537-45
pubmed: 11153906
EMBO J. 2001 Sep 17;20(18):5060-9
pubmed: 11566871
J Hum Genet. 2002;47(7):333-41
pubmed: 12111366
Mol Cell Biol. 2004 Jan;24(2):527-36
pubmed: 14701727
Pediatr Res. 2004 Oct;56(4):608-14
pubmed: 15295082
J Nutr. 2006 Jan;136(1 Suppl):250S-3S
pubmed: 16365092
J Inherit Metab Dis. 2008 Jun;31(3):386-94
pubmed: 18415701
J Hepatol. 2008 Nov;49(5):810-20
pubmed: 18620775
Rapid Commun Mass Spectrom. 2009 May;23(10):1483-92
pubmed: 19350529
Cell Cycle. 2010 Oct 1;9(19):3884-6
pubmed: 20948290
Mol Genet Metab. 2012 Nov;107(3):322-9
pubmed: 22921887
Orphanet J Rare Dis. 2013 Jul 09;8:98
pubmed: 23835272
Mol Genet Metab. 2015 Jan;114(1):1-10
pubmed: 25467056
Biochim Biophys Acta. 2015 Mar;1852(3):473-81
pubmed: 25533124
Biochim Biophys Acta. 2015 Aug;1847(8):729-38
pubmed: 25917893
J Lipid Res. 1989 Nov;30(11):1811-7
pubmed: 2614280
Amino Acids. 2016 Jan;48(1):1-20
pubmed: 26259930
Springerplus. 2015 Sep 15;4:494
pubmed: 26389019
Mol Genet Metab. 2017 Mar;120(3):207-212
pubmed: 28041819
J Inherit Metab Dis. 1985;8(2):75-9
pubmed: 3939535
J Biol Chem. 1979 Apr 25;254(8):2669-76
pubmed: 429309
Arch Biochem Biophys. 1994 Feb 1;308(2):349-56
pubmed: 8109964